Cynthia Flowers

Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ.

Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics to address unmet medical need. The company's clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies. The firms late-stage product candidate KD025, which is an orally administered selective inhibitor of Rho-associated coiled-coil kinase engages in development for the treatment of inflammatory and fibrotic diseases. The firm's a pivotal clinical trial of KD025 is underway in chronic graft-versus-host disease (cGVHD), as well as a Phase 2 clinical trial in systemic sclerosis. It is also developing next-generation immuno-oncology therapies, specifically IL-15 containing fusion proteins, for the treatment of cancer. The company's lead I-O product candidate, KD033, is an anti-PD-L1/IL-15 fusion protein. Kadmon was founded by Steven N. Gordon in September 2010 and is headquartered in New York, NY.

Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ.

National Association of Corporate Directors provides online and print information services to directors of public companies. It offers in-boardroom education, evaluation, governance reviews, board composition and succession planning, board recruitment, ongoing advisory, insights, and analytics services. The company was founded in 1977 and is headquartered in Arlington, VA.

Part of Relevate Health Group, Inc., Cyber X Designs LLC operates as a digital healthcare marketing agency. The company is based in Rochelle Park, NJ. The company was founded in 1999 by Hans C. Kaspersetz. Cyber X Designs was acquired by Relevate Health Group, Inc. on December 21, 2020.

Hikma Ventures Ltd. (Hikma Ventures) is a venture capital arm of Hikma Pharmaceuticals Plc founded in 2015. The firm is headquartered in London, United Kingdom.

Part of Mountaingate Management Co LLC, Relevate Holdings LP is a company that provides business services. The company is based in Denver, CO.

Eternatear, Inc.is developing an OTC product that treats progressive dry eye. The company is headquartered in Raleigh, NC.

Relevate Health Group provides health marketing and deployment services. It operates the following companies: Healthcare Regional Marketing and Spirit Health Group. The company was founded in 2015 and is headquartered in Cincinnati, OH.

Omeza Holdings, Inc. provides healthcare services. The company is based in Sarasota, FL. Cynthia L. Flowers has been the CEO of the company since 2023.